Sherri Douville chairs the Trustworthy Technology & Innovation Consortium (TTIC), AIMed's 2026 partner behind the High-Reliability Agentic AI Track. She is CEO and architect of Medigram, whose Darwin platform and agentic fleet run in production as the reference implementation of IEEE UL 2933, independently verified at the highest recorded behavioral score. She co-chairs the standard's Trust Subgroup and co-authored the Hospital AI Operations Governance Standard, ANSI/HSI 2800:2025. She is a six-time published author and series editor with Taylor & Francis, with a forthcoming volume on AI and cybersecurity for healthcare boards. She works from policy to code: the standards she helps author run in production as verified operating controls of her design. She chaired the High-Reliability AI Track at AIMed 2025, received the 2025 AIMed AI Champion Award, and builds the field's multi-domain talent network through TTIC. Previously, Ms. Douville worked at Johnson & Johnson for over a decade across more than a dozen disease areas, winning several awards, and has held Series 7 and Series 66 securities licenses.